Abbott has launched a “next-generation” delivery system to streamline the electrode implantation process for its Proclaim DRG neurostimulation system. This advancement aims to improve treatments for ...

Abbott (NYSE: ABT) announced today that it launched a next-generation delivery system for its neuromodulation business.

Abbott today announced the launch of its neuromodulation business’ next-generation delivery system, which will be used to streamline the implantation process for electrodes used as part of its ...